• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经保护肽 NAP 不会直接影响重组神经微管的聚合或动力学。

The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules.

机构信息

Department of Molecular, The Neuroscience Research Institute, University of California, Santa Barbara, Santa Barbara, CA 93106-9610, USA.

出版信息

J Alzheimers Dis. 2010;19(4):1377-86. doi: 10.3233/JAD-2010-1335.

DOI:10.3233/JAD-2010-1335
PMID:20061604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2844470/
Abstract

NAP (Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln) is a neuroprotective peptide that shows cognitive protection in patients with amnestic mild cognitive impairment, a precursor to Alzheimer's disease. NAP exhibits potent neuroprotective properties in several in vivo and cellular models of neural injury. While NAP has been found in many studies to affect microtubule assembly and/or stability in neuronal and glial cells at fM concentrations, it has remained unclear whether NAP acts directly or indirectly on tubulin or microtubules. We analyzed the effects of NAP (1 fM-1 microM) on the assembly of reconstituted bovine brain microtubules in vitro and found that it did not significantly (p< 0.05) alter polymerization of either purified tubulin or of a mixture of tubulin and unfractionated microtubule-associated proteins. NAP also had no significant effect (p < 0.05) on the growing and shortening dynamics of steady-state microtubules at their plus ends, nor did it alter the polymerization or dynamics of microtubules assembled in the presence of 3-repeat or 4-repeat tau. Thus, the neuroprotective activity of NAP does not appear to involve a direct action on the polymerization or dynamics of purified tubulin or microtubules.

摘要

NAP(天冬酰胺-丙氨酸-脯氨酸-缬氨酸-丝氨酸-异亮氨酸-脯氨酸-谷氨酰胺)是一种具有神经保护作用的肽,在遗忘型轻度认知障碍患者(阿尔茨海默病的前驱期)中具有认知保护作用。NAP 在几种体内和细胞神经损伤模型中均表现出强大的神经保护作用。虽然在许多研究中发现 NAP 在 fM 浓度下影响神经元和神经胶质细胞中的微管组装和/或稳定性,但尚不清楚 NAP 是否直接或间接作用于微管蛋白或微管。我们分析了 NAP(1 fM-1 microM)对体外重组牛脑微管组装的影响,发现它对纯化微管蛋白或微管蛋白和未分级微管相关蛋白混合物的聚合均无显著影响(p<0.05)。NAP 对稳态微管末端的生长和缩短动力学也没有显著影响(p<0.05),也不会改变 3 重复或 4 重复 tau 存在下组装的微管的聚合或动力学。因此,NAP 的神经保护活性似乎不涉及对纯化微管蛋白或微管的聚合或动力学的直接作用。

相似文献

1
The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules.神经保护肽 NAP 不会直接影响重组神经微管的聚合或动力学。
J Alzheimers Dis. 2010;19(4):1377-86. doi: 10.3233/JAD-2010-1335.
2
The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.飞摩尔作用的NAP与微管相互作用:星形胶质细胞保护的新方面。
J Alzheimers Dis. 2004 Dec;6(6 Suppl):S37-41. doi: 10.3233/jad-2004-6s605.
3
NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).中性粒细胞碱性磷酸酶(NAP)和二甲基亚砜(D-SAL):对β淀粉样肽(1-42)的神经保护作用
BMC Neurosci. 2008 Dec 10;9 Suppl 3(Suppl 3):S3. doi: 10.1186/1471-2202-9-S3-S3.
4
Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide).新型微管蛋白和tau神经保护片段,与候选药物NAP(达武肽)具有结构相似性。
J Alzheimers Dis. 2014;40 Suppl 1:S23-36. doi: 10.3233/JAD-131664.
5
NAP protects against cyanide-related microtubule destruction.NAP 可防止与氰化物相关的微管破坏。
J Neural Transm (Vienna). 2009 Nov;116(11):1411-6. doi: 10.1007/s00702-009-0252-7. Epub 2009 Jun 24.
6
Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP).微管稳定肽和小分子保护轴突运输和大脑功能:以 davunetide(NAP)为重点。
Neuropeptides. 2013 Dec;47(6):489-95. doi: 10.1016/j.npep.2013.10.011. Epub 2013 Oct 24.
7
NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell.NAP是一种处于临床试验阶段的神经保护候选药物,可刺激活细胞中的微管组装。
Curr Alzheimer Res. 2007 Dec;4(5):507-9. doi: 10.2174/156720507783018208.
8
Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage.在阿尔茨海默病早期病理阶段的转基因小鼠模型中,经鼻给予NAP可减少淀粉样肽的积累和tau蛋白的过度磷酸化。
J Mol Neurosci. 2007;31(2):165-70. doi: 10.1385/jmn/31:02:165.
9
Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.通过药物候选物 NAP(达文西肽)和 D-SAL 防治 Tau 病:生化、细胞和行为方面。
Curr Pharm Des. 2011;17(25):2603-12. doi: 10.2174/138161211797416093.
10
Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.活性依赖型神经保护蛋白(ADNP)-末端结合蛋白(EB)相互作用调节微管动力学,以防止 tau 病。
Prog Mol Biol Transl Sci. 2021;177:65-90. doi: 10.1016/bs.pmbts.2020.07.008. Epub 2020 Aug 14.

引用本文的文献

1
Pharmacological Potential of Bioactive Peptides for the Treatment of Diseases Associated with Alzheimer's and Brain Disorders.生物活性肽治疗与阿尔茨海默病和脑部疾病相关疾病的药理学潜力。
Curr Mol Med. 2024;24(8):962-979. doi: 10.2174/1566524023666230907115753.
2
Natural Plant Materials as a Source of Neuroprotective Peptides.天然植物材料作为神经保护肽的来源。
Curr Med Chem. 2024;31(31):5027-5045. doi: 10.2174/0929867331666230703145043.
3
Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism.

本文引用的文献

1
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.在一种tau蛋白病模型中,NAP可保护记忆、增加可溶性tau蛋白并减少tau蛋白的过度磷酸化。
Neurobiol Dis. 2009 May;34(2):381-8. doi: 10.1016/j.nbd.2009.02.011. Epub 2009 Mar 2.
2
Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.淀粉样β肽聚集与tau蛋白过度磷酸化:阿尔茨海默病中的关系及联系
J Alzheimers Dis. 2009;16(1):15-27. doi: 10.3233/JAD-2009-0960.
3
NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42).
染色质重塑酶活性依赖性神经保护蛋白(ADNP)与综合征型自闭症有关。
Clin Epigenetics. 2023 Mar 21;15(1):45. doi: 10.1186/s13148-023-01450-8.
4
Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases.微管功能障碍:神经退行性疾病的共同特征。
Int J Mol Sci. 2020 Oct 5;21(19):7354. doi: 10.3390/ijms21197354.
5
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide.利用噬菌体展示肽自组装的纳米配体药物载体穿越血脑屏障。
Nat Commun. 2019 Oct 11;10(1):4635. doi: 10.1038/s41467-019-12554-2.
6
Reduction of aluminum ion neurotoxicity through a small peptide application - NAP treatment of Alzheimer's disease.通过应用小肽减少铝离子神经毒性 - NAP 治疗阿尔茨海默病。
J Food Drug Anal. 2019 Apr;27(2):551-564. doi: 10.1016/j.jfda.2018.11.009. Epub 2019 Jan 12.
7
Repositioning Microtubule Stabilizing Drugs for Brain Disorders.重新定位用于脑部疾病的微管稳定药物。
Front Cell Neurosci. 2018 Aug 8;12:226. doi: 10.3389/fncel.2018.00226. eCollection 2018.
8
ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect.ADNP,一种微管相互作用蛋白,通过末端结合蛋白和tau蛋白提供神经保护:一种放大效应。
Front Mol Neurosci. 2018 May 1;11:151. doi: 10.3389/fnmol.2018.00151. eCollection 2018.
9
ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.ADNP/NAP 显著增加微管末端结合蛋白-Tau 的相互作用:一种针对 Tau 病的新型保护途径。
Mol Psychiatry. 2017 Sep;22(9):1335-1344. doi: 10.1038/mp.2016.255. Epub 2017 Jan 24.
10
Notch signalling in adult neurons: a potential target for microtubule stabilization.成年神经元中的 Notch 信号:微管稳定的潜在靶点。
Ther Adv Neurol Disord. 2013 Nov;6(6):375-85. doi: 10.1177/1756285613490051.
中性粒细胞碱性磷酸酶(NAP)和二甲基亚砜(D-SAL):对β淀粉样肽(1-42)的神经保护作用
BMC Neurosci. 2008 Dec 10;9 Suppl 3(Suppl 3):S3. doi: 10.1186/1471-2202-9-S3-S3.
4
Activity-dependent neuroprotective protein-derived peptide, NAP, preventing alcohol-induced apoptosis in fetal brain of C57BL/6 mouse.活性依赖的神经保护蛋白衍生肽(NAP)可预防C57BL/6小鼠胎脑中酒精诱导的细胞凋亡。
Neuroscience. 2009 Feb 18;158(4):1426-35. doi: 10.1016/j.neuroscience.2008.11.021. Epub 2008 Nov 21.
5
Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane.萝卜硫素对MCF7乳腺癌细胞微管动态不稳定性和周转的抑制作用。
Carcinogenesis. 2008 Dec;29(12):2360-8. doi: 10.1093/carcin/bgn241. Epub 2008 Oct 23.
6
FTDP-17 mutations in Tau alter the regulation of microtubule dynamics: an "alternative core" model for normal and pathological Tau action.Tau蛋白中的额颞叶痴呆伴帕金森综合征17型(FTDP-17)突变改变了微管动力学的调节:一种关于正常和病理性Tau蛋白作用的“替代核心”模型
J Biol Chem. 2008 Dec 26;283(52):36406-15. doi: 10.1074/jbc.M803519200. Epub 2008 Oct 21.
7
VIP, from gene to behavior and back: summarizing my 25 years of research.血管活性肠肽,从基因到行为再回归:总结我25年的研究历程
J Mol Neurosci. 2008 Nov;36(1-3):115-24. doi: 10.1007/s12031-008-9105-3. Epub 2008 Jul 8.
8
AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders.AL - 108和AL - 208,即活性依赖神经保护蛋白的神经保护NAP片段的制剂,用于治疗认知障碍。
Curr Opin Investig Drugs. 2008 Jul;9(7):800-11.
9
Microtubule stabilization specifies initial neuronal polarization.微管稳定作用决定了神经元最初的极化。
J Cell Biol. 2008 Feb 11;180(3):619-32. doi: 10.1083/jcb.200707042.
10
NAP, a neuroprotective drug candidate in clinical trials, stimulates microtubule assembly in the living cell.NAP是一种处于临床试验阶段的神经保护候选药物,可刺激活细胞中的微管组装。
Curr Alzheimer Res. 2007 Dec;4(5):507-9. doi: 10.2174/156720507783018208.